No Data
No Data
Notable Labs Advances With Phase 2 Trial for Volasertib
Express News | Notable Labs Shares Are Trading Lower. The Company Announced Progress for Its Phase 2 Volasertib Program
Express News | Notable Labs Announced Progress For The Phase 2 Volasertib Program Following Receipt Of "Clearance To Proceed" From The FDA And Agreement On The Dosing Plan For Its Phase 2 Clinical Trial
Express News | Notable Labs: To Initiate Enrollment in Phase 2 Study for Pmp-Enabled Development of Volasertib for R/R Acute Myeloid Leukemia (Aml) in Coming Months
Express News | Notable Labs Ltd: Agreement on Dosing Plan for Its Phase 2 Clinical Trial
Express News | Notable Labs Receives FDA Clearance to Proceed Further With Volasertib Phase 2 Study
No Data